Drug Interactions Discovered Post-Market: What It Means for Patient Safety
Discover why drug interactions are often missed in clinical trials and detected only after widespread use. Learn how post-market surveillance systems like FAERS protect patients and what you can do to stay safe.
How to Participate in Patient Registries for Drug Safety: A Complete Guide
Learn how to join patient registries for drug safety. Understand mandatory vs. voluntary options, data privacy, and step-by-step enrollment processes.
International Drug Safety Monitoring Systems Explained
International drug safety monitoring systems collect and analyze global reports of adverse drug reactions to protect public health. Powered by WHO's VigiBase and regional networks like EudraVigilance, they detect hidden risks, but face major gaps in low-income countries.